Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning
- 577 Downloads
Individuals at increased risk for pancreatic cancer who undergo screening can experience psychological and emotional distress. The objective of this study is to determine whether individuals participating in a pancreatic cancer screening program experience disruptions in risk perception, cancer-related anxiety or emotional distress. A pretestposttest design was used to examine perceived risk and psychological functioning of individuals participating in a pancreatic cancer screening protocol. The screening protocol includes genetic counselling, transcutaneous abdominal ultrasound, magnetic resonance imaging, and blood collection and eligible participants included individuals with a family history of pancreatic cancer or BRCA2 mutation carriers. At baseline, participants (n = 198) showed low to moderate levels of risk perception, pancreatic cancer-related anxiety, and general distress. Participants with familial pancreatic cancer (FPC) (n = 131) endorsed higher risk perception of pancreatic cancer than the BRCA2 carriers (n = 67) (perceived lifetime risk 42 vs. 15%), but did not differ on cancer worry or general distress prior to the first study appointment. From baseline to 3 months follow-up, no significant time or time by group interactions emerged on risk perception or general distress, but cancer worry decreased over time for the FPC group regardless of the number of affected relatives. Our findings indicate that participation in a pancreatic cancer screening program does not lead to a significant increase in risk perception, cancer worry, or general distress and that participants with high baseline levels of risk perception and distress may benefit from a more comprehensive risk assessment and psychological support.
KeywordsBRCA2 Cancer worry Distress Familial pancreatic cancer Risk perception Screening
We thank the Pancreatic Cancer Canada foundation (www.pancreaticcancercanada.ca) for their continued support of research into the early detection of pancreatic cancer, and the Pancreas Cancer Screening Study at Mount Sinai Hospital and Princess Margaret Hospital. We also thank Kate Butler, Laura Mehedan and Jiahui Wong for their critical review on an earlier draft of this manuscript.
- 1.CCS/NCIC (2008) Canadian Cancer Statistics 2008. In: Society CC (ed) Canadian Cancer Society/National Cancer Institute of Canada. Vol 2008, TorontoGoogle Scholar
- 7.Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI (2007) Participants of the Fourth International Symposium of Inherited Diseases of the P. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 56:1460–1469CrossRefPubMedGoogle Scholar
- 8.BCLC (1999) Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Nat Cancer Inst 91:1310–1316Google Scholar
- 16.Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K, Ali SZ, Jagannath S, Petersen GM, Fishman EK, Piantadosi S, Giardiello FM, Hruban RH (2004) Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2:606–621CrossRefPubMedGoogle Scholar
- 17.Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, Fishman EK, Brune K, Axilbund J, Griffin C, Ali S, Richman J, Jagannath S, Kantsevoy SV, Kalloo AN (2006) Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. [see comment]. Clin Gastroenterol Hepatol 4:766–781; quiz 665Google Scholar
- 32.Brain K, Henderson BJ, Tyndel S, Bankhead E, Watson A, Clements A, Austoker J (2008) Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psycho-Oncology 1057–9249 (in press)Google Scholar
- 33.CCS. Canadian Cancer Statitics 2009. In: Canada CCSNCIo (ed) Canadian Cancer Society, 2009Google Scholar
- 34.van Dijk S, Otten W, Zoeteweij MW, Timmermans DRM, van Asperen CJ, Breuning MH, Tollenaar RA, Kievit J (2003) Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment. Br J Cancer 88:1675–1681Google Scholar
- 38.Croyle RT, Lerman C (1999) Risk communication in genetic testing for cancer susceptibility. J Nat Cancer Inst. Monographs 59–66Google Scholar